The two companies focus on research, development and commercialization of sterile packaged implants and surgical tools for spinal fusion.
Back 2 Basics Direct and Orbbö Surgical represent Wishbone Medical’s fifth and sixth acquisitions in the past 18 months, according to an Aug. 5 announcement.
The acquisitions add nine FDA-cleared spinal fusion products to Wishbone Medical’s portfolio, which is expected to bring more than $12 million in year one revenue for the company.
Twenty spine-focused employees will be added to Wishbone Medical’s global team of 165.
More articles on devices:
Acquisitions, leadership changes & more: 6 big moves from Medtronic
Zimmer Biomet’s worldwide knee sales plummet 46.8% in Q2, hitting $374M
9 spine surgeons stepping into new leadership roles
